Filter
353
Text search:
illicit
drug
abuse
Featured
Recommendations
14
New Publications
57
Language
Document type
No document type
283
Studies & Reports
30
Guidelines
15
Strategic & Response Plan
9
Manuals
6
Situation Updates
3
Resource Platforms
2
Fact sheets
2
Training Material
1
Brochures
1
Infographics
1
Countries / Regions
Western and Central Europe
17
Global
13
Ukraine
11
India
9
Kenya
9
Nigeria
8
Eastern Europe
7
Asia
6
Sierra Leone
5
Ethiopia
5
Liberia
4
Myanmar / Burma
4
South–East Asia Region
4
Tajikistan
4
Nepal
3
Zambia
3
Rwanda
3
Indonesia
3
South Africa
3
Eswatini/ Swaziland
3
Colombia
3
Africa
3
Albania
3
Russia
3
USA
2
Uganda
2
Pakistan
2
Afghanistan
2
Tanzania
2
Malawi
2
Namibia
2
Botswana
2
Lesotho
2
Latin America and the Carribbean
2
Canada
2
Moldova
2
Congo, Democratic Republic of
1
Ghana
1
Zimbabwe
1
Philippines
1
Somalia
1
South Sudan
1
Germany
1
Syria
1
Cambodia
1
Thailand
1
Bangladesh
1
Sudan
1
Central African Republic
1
Peru
1
North Macedonia
1
Serbia
1
El Salvador
1
Mexico
1
Sri Lanka
1
Eastern Europe and Central Asia
1
Bhutan
1
Venezuela
1
Iran
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
Vietnam
1
Authors & Publishers
Publication Years
Category
Countries
80
Clinical Guidelines
14
Public Health
11
Women & Child Health
7
Key Resources
6
Capacity Building
3
Toolboxes
Mental Health
168
HIV
46
TB
33
NCDs
7
Conflict
5
Ebola & Marburg
3
Global Health Education
3
AMR
3
Pharmacy
3
Caregiver
2
Disability
1
Natural Hazards
1
Refugee
1
COVID-19
1
NTDs
1
Health Financing Toolbox
1
A summary of the national drug situation
Perspectives on drugs
Accessed: 28.03.2019
A summary of the national drug situation
A summary of the national drug situation
EMCDDA Insights - 11
Accessed: 14.03.2019
Accessed: 22.03.2019
Harm reduction: evidence, impacts and challenges
-10-
Perspective on drugs
Perspectives on Drugs
Opiates, cocaine, cannabis
World Drug Report 2017
-3-
Accessed: 14.03.2019
Amphetamine-type stimulants, new psychoactive substances
-4-
World Drug Report 2017
Accessed: 14.03.2019
International Journal of Drug Policy 24 (2013) e91-98